ALLERGY THERAPEUTICS
They have provided general information for the allergy sufferer and healthcare professionals about the prevention, diagnosis and treatment of the allergic condition with a special focus on allergy vaccination (also known as specific immunotherapy or desensitisation therapy), the only treatment to deal with the underlying cause and not just the symptoms!
ALLERGY THERAPEUTICS
Industry:
Health Care Health Diagnostics Medical
Founded:
1934-01-01
Address:
Worthing, West Sussex, United Kingdom
Country:
United Kingdom
Website Url:
http://www.allergytherapeutics.com
Total Employee:
501+
Status:
Active
Contact:
+4401903844700
Total Funding:
30 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Tag Manager Content Delivery Network Domain Not Resolving Apache Mobile Non Scaleable Content Microsoft Exchange Online
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2015-06-05 | Alerpharma | Alerpharma acquired by Allergy Therapeutics | N/A |
| 2010-07-02 | TEOMED | TEOMED acquired by Allergy Therapeutics | 1.2 M CHF |
Official Site Inspections
http://www.allergytherapeutics.com
- Host name: 52.156.206.29
- IP address: 52.156.206.29
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
- Postal: D02
More informations about "Allergy Therapeutics" on Search Engine
Overview | Allergy Therapeutics PLC
Overview. We are a market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments. We believe that …See details»
Annual Report 2021 | Allergy Therapeutics PLC
Allergy Therapeutics PLC ; Results, reports and presentations ; Annual Report 2021 . Overview ; At a glance ; Investment case . Business model; Strategy. Regulatory news ; …See details»
Allergy Therapeutics - Crunchbase Company Profile & Funding
About. Allergy Therapeutics (AT) is a European-based speciality pharmaceutical company focused upon the treatment and prevention of allergy. Worthing, West Sussex, United …See details»
Allergy Therapeutics Selects AGC Biologics to Manufacture
Seattle, March 31, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), …See details»
Treatment Pathway - Schroeder Allergy and Immunology …
Treatment Pathway. Overview Scientific Progress Community Engagement. The mission of the institute’s Treatment Pathway is to make impactful discoveries about the immune …See details»
Our markets | Allergy Therapeutics PLC
Our markets. Allergy Therapeutics continues to maintain a strong presence in Europe with established operations in 19 markets, either directly or via partnerships. Germany remains the Group’s main market, …See details»
Allergen immunotherapy: past, present and future | Nature …
Oct 17, 2022 84 Citations. 47 Altmetric. Metrics. Abstract. Allergen immunotherapy is a form of therapeutic vaccination for established IgE-mediated hypersensitivity to …See details»
Allergy Therapeutics Selects AGC Biologics to Manufacture …
Seattle, March 31, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), …See details»
Allergen Immunotherapy: Current and Future Trends - PMC
Jan 8, 2022 Allergen immunotherapy (AIT) is the sole disease-modifying treatment for allergic rhinitis; it prevents rhinitis from progressing to asthma and lowers medication …See details»
Angany: a new generation of allergen immunotherapy - Nature
Produced by. Allergy is at pandemic levels: currently ranked as the fourth global health threat by the World Health Organization, one in three individuals born after 1990 is …See details»
Clinical trials in allergen immunotherapy: current concepts and …
Apr 16, 2018 Allergen immunotherapy (AIT) is a safe, effective treatment for allergic rhinoconjunctivitis and allergic asthma. However, AIT's clinical effect is still …See details»
Home | ANGANY
About ANGANY. ANGANY is an innovative pharmaceutical company dedicated to allergy immunotherapy. ANGANY is bringing hope to the millions of people affected by allergy.See details»
Dogmas, challenges, and promises in phase III allergen …
Sep 28, 2021 Dogmas, challenges, and promises in phase III allergen immunotherapy studies - World Allergy Organization Journal. Review Article | Volume 14, ISSUE 9, …See details»
One hundred and ten years of Allergen ... - Wiley Online Library
First published: 27 July 2021. https://doi.org/10.1111/all.15023. Citations: 23. Sections. PDF. Tools. Share. Abstract. One hundred and ten years after Noon's first clinical report of the …See details»
A therapeutic strategy to target distinct sources of IgE and durably ...
13 Dec 2023. Vol 15, Issue 726. DOI: 10.1126/scitranslmed.adf9561. Editor’s summary. IgE antibodies are primary drivers of allergic disorders, and a strategy to both eliminate …See details»
About Us - Allergy Canada
About Us - Allergy Canada. Why to choose Allergy Canada? Canadian based company focused on and committed to the Canadian allergist for over 10 years. Health Canada …See details»
About Us | AllerVie Health | Asthma & Allergy Providers
Care. Happiness. Integrity. Service. Our Commitment. We put our patients at the heart of everything we do and are committed to setting and delivering the gold-standard in …See details»
World Allergy Organization
World Allergy Organization. To be a global resource and advocate in the field of allergy, advancing excellence in clinical care through education, research and training as a world …See details»
Therapeutic vaccines for allergic disease - PubMed
May 8, 2017 Abstract. Allergic diseases are highly prevalent worldwide and affect all age groups, contributing to a high personal and socioeconomic burden. Treatment with an …See details»